Dr RR Baliga's "Got Knowledge Doc" Podkast

The New England Journal of Medicine has now given us randomized trial evidence for a question long guided more by extrapolation than by direct proof: in patients with established atherosclerotic cardiovascular disease, targeting LDL cholesterol to

Elegant trial, practical message: when risk is high, lower may truly be better. 🫀📉🎯 Journal: New England Journal of Medicine.

New in Circulation: the 2026 AHA Dietary Guidance to Improve Cardiovascular Health distills prevention into 9 elegant features—maintain healthy weight, emphasize vegetables/fruits, choose whole grains, favor healthier proteins and unsaturated fats, minimize ultraprocessed foods, added sugars, and sodium, and avoid starting alcohol for health. Food, here, is not garnish; it is strategy. 🥗🌾🩺 #Cardiology #Preven

📚 From prisons to clinics to classrooms — what really shapes us?

I've been exploring the philosophical work of Michel Foucault, and one idea keeps echoing:

👉 Power isn't just something imposed from above — it quietly operates through systems, language, and everyday norms.

From how we define "normal" to how institutions like schools, hospitals, and prisons function, Foucault challenges us to rethink what we take for granted.

🔍 His work invites us to ask:

• Who defines truth?

• How do labels shape identity?

• When does care become control?

Whether you're in education, healthcare, research, or leadership, these questions feel surprisingly relevant today.

🧠 Sometimes the most powerful shift is not in changing the world — but in seeing it differently.

#Philosophy #Foucault #CriticalThinking #Education #Healthcare #Leadership #IntellectualCuriosity #IdeasThatMatter

Left atrial appendage closure—promise meets proof, and proof meets pause.

In The New England Journal of Medicine, two pivotal trials draw a nuanced arc:

CHAMPION-AF shows noninferior stroke prevention with less bleeding vs direct oral anticoagulants, while CLOSURE-AF tempers enthusiasm—failing noninferiority in older, high-risk patients with meaningful procedural risk.

The message is elegant and sobering: innovation must bow to evidence, and patient selection remains paramount.

In atrial fibrillation, the art lies not in closing the appendage—but in opening judgment.

Evolocumab steps into primary prevention—quietly, convincingly. In JAMA, the VESALIUS-CV analysis shows that high-risk patients with diabetes without known atherosclerosis experienced a 31% relative reduction in first MACE (HR 0.69), with LDL-C lowered to ~52 mg/dL. The signal is clear: earlier, deeper lipid lowering matters. Yet questions remain—cost, long-term safety, and who benefits most. Are we ready to treat risk before disease declares itself? 🧠💉📉 #JAMA #Cardiology #Prevention

A quiet valve, a loud message. 🫀

The 10-year follow-up of the RECOVERY trial in The New England Journal of Medicine shows that early surgery in asymptomatic very severe aortic stenosis is not premature—it is protective.

A striking reduction in cardiovascular mortality (HR 0.10, P=0.002) and sustained divergence of Kaplan–Meier curves challenge the long-held "watchful waiting" paradigm.

Perhaps we are not treating symptoms—but preventing myocardial destiny.

#Cardiology #AorticStenosis #NEJM #PrecisionMedicine

Cardiology stands at a quiet inflection point.

We have spent decades treating plaque—yet the real opportunity lies upstream: preventing atheroma before it begins. Emerging evidence reminds us that cumulative LDL exposure, not just snapshots of risk, shapes lifelong cardiovascular destiny.

A shift is underway:

→ From 10-year risk to lifetime risk

→ From reactive care to proactive prevention

→ From treating disease to preserving vascular resilience

Lower LDL earlier. Sustain it longer.

That is not just prevention—it is strategy, science, and stewardship.

#Cardiology #Prevention #Atherosclerosis #LDL #PrecisionMedicine

Resistant Hypertension remains one of the most under-recognized yet high-risk phenotypes in cardiovascular medicine.

Nearly 1 in 5 treated patients meet criteria for apparent resistance—and up to half may reflect nonadherence or white-coat effect.

This concise visual series distills key insights from a recent JAMA review on diagnosis, pathophysiology, and stepwise management—including the pivotal role of spironolactone and emerging therapies like renal denervation.

Precision begins with correct classification. Treatment begins with clarity. 💡

#Hypertension #Cardiology #PrecisionMedicine #JAMA

Sound. Mask. Mastery 🎼

A fascinating insight from C. V. Raman reminds us that hearing is not just perception—it is physics in motion. His 1926 Nature note reveals how lower tones quietly veil higher ones, shaping what we think we hear.

In music—and in science—what is hidden often matters most.

#Acoustics #CVRaman #Psychoacoustics #SoundScience #NatureJournal

Yajnavalkya: Vedic Sage • Radical Thinker • Timeless Voice 🕉️📜✨

What does it mean to know the Self? Long before modern philosophy, Yajnavalkya in the Brihadaranyaka Upanishad asked—and answered—with striking clarity.

"Neti, Neti" (not this, not this) strips illusion, revealing the essence of consciousness—Atman as Brahman.

In dialogues with Maitreyi and Gargi, he models fearless inquiry, intellectual rigor, and spiritual depth.

Ancient, yet urgent. Subtle, yet transformative.

#IndianPhilosophy #Vedanta #Yajnavalkya #Consciousness #Wisdom